A novel FOXM1 target, PIK3R3, was identified, and its overexpression was not only shown to mediate FOXM1-activation of the PI3K/AKT pathway, but also to confer poor prognosis to ESCC patients. This evidence concerns the gene FOXM1 and esophageal squamous cell carcinoma.